Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Bulletin De L'Academie Nationale De Medecine|August 13, 2015
[Drug therapy of melanoma: anti-CTLA-4 and anti-PD-1 antibodies]Caroline Robert, Christina MateusBulletin Du Cancer|March 18, 2015
[Immunotherapies and melanoma]Émilie Routier, Caroline Robert, Christina MateusJournal of the American Academy of Dermatology|November 26, 2008
Dermatologic symptoms associated with the multikinase inhibitor sorafenibCaroline Robert, Christina Mateus, Alain Spatz, et al.The Lancet. Oncology|April 8, 2015
Nail toxicities induced by systemic anticancer treatmentsCaroline Robert, Vincent Sibaud, Christina Mateus, et al.Palliative & Supportive Care|August 22, 2022
Decisions about treatment with targeted therapies in a palliative care unit: A case seriesMatthieu Delaye, Perrine Renard, Anda Sampetrean, et al.La Revue Du Praticien|March 22, 2014
[Management of patients with melanoma]Caroline Robert, Andrea Cavalcanti, Frédéric Kolb, et al.International Journal of Clinical Pharmacy|March 20, 2012
Cutaneous side effects associated with sunitinib: an analysis of 8 casesClaire Vignand-Courtin, Caroline Martin, Christine Le Beller, et al.Bulletin Du Cancer|March 19, 2013
[Impact of cutaneous toxicities associated with targeted therapies on quality of life. Results of a longitudinal exploratory study]Cécile Charles, Serge Sultan, Catherine Bungener, et al.Pediatric Blood & Cancer|June 28, 2016
Cutaneous malignant melanoma in children and adolescents treated in pediatric oncology unitsYves Réguerre, Marie Vittaz, Daniel Orbach, et al.Pageof 2